The charts on this page feature a breakdown of the total annual pay for the top executives at EXELIXIS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. EXELIXIS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. EXELIXIS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Michael M. Morrissey Ph.D
President and Chief Executive Officer
Total Cash $2,358,918 Equity $5,160,513 Other $11,000 Total Compensation $7,530,431
Gisela M. Schwab M.D.
Former President, Product Development and Medical Affairs and Chief Medical Officer
Total Cash $557,210 Equity $8,300,914 Other $11,000 Total Compensation $8,869,124
Jeffrey J. Hessekiel J.D.
Executive Vice President, General Counsel and Secretary
Total Cash $946,204 Equity $1,217,547 Other $11,000 Total Compensation $2,174,751
Peter Lamb Ph.D.
Executive Vice President, Scientific Strategy and Chief Scientific Officer
Total Cash $898,455 Equity $1,052,607 Other $11,000 Total Compensation $1,962,062
Christopher J. Senner
Executive Vice President and Chief Financial Officer
Total Cash $1,079,075 Equity $1,367,037 Other $11,000 Total Compensation $2,457,112
Patrick J. Haley
Executive Vice President, Commercial
Total Cash $835,435 Equity $1,269,437 Other $11,000 Total Compensation $2,115,872
For its 2021 fiscal year, EXELIXIS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Michael M. Morrissey Ph.D CEO Pay $7,530,431 Median Employee Pay $283,758 CEO Pay Ratio 27:1
For its 2021 fiscal year, EXELIXIS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Alan M. Garber, M.D., Ph.D. Total Cash $423,120
Carl B. Feldbaum, Esq. Total Cash $423,120
Charles Cohen, Ph.D. Total Cash $449,120
George Poste, DVM, Ph.D., FRS Total Cash $439,212
Jack L. Wyszomierski Total Cash $441,264
Jacqueline Wright Total Cash $703,920
Julie A. Smith Total Cash $449,212
Lance Willsey, M.D. Total Cash $425,120
Maria C. Freire, Ph.D. Total Cash $426,264
Stelios Papadopoulos Total Cash $467,212
Vincent T. Marchesi Total Cash $435,264

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.